• Defining Nonresponse to PBC Treatment: Curbside Consults Podcast

  • Feb 24 2025
  • Length: 19 mins
  • Podcast

Defining Nonresponse to PBC Treatment: Curbside Consults Podcast

  • Summary

  • How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including:

    • How and when to measure treatment response
    • Evidence-based goals of therapy
    • Considerations for second-line treatment
    • New agents for second-line treatment: PPAR agonists

    Presenters:

    Alan Bonder, MD, AGAF
    Associate Professor of Medicine
    Medical Director of Liver Transplant
    Department of Gastroenterology
    Beth Israel Deaconess Medical Center
    Harvard Medical School
    Boston, Massachusetts

    Aparna Goel, MD
    Associate Clinical Professor of Medicine
    Division of Gastroenterology and Hepatology
    Stanford University
    Palo Alto, California

    Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc​.

    To learn more about PBC management, check out our program,
    Curbside Consults: Expert Insights on Challenges in PBC Management.

    Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Defining Nonresponse to PBC Treatment: Curbside Consults Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.